//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
Clinical Geneticist, VCGS. Professor, University of Melbourne. Rare disease genomics. ๐Ÿงฌ๐Ÿ‡ฆ๐Ÿ‡บ
Zornitza Stark
๐Ÿงฌ Suzi Walker, Genomics England Can RNAseq help solve more rare disease cases? RNAseq from 7,841 participants in the 100kgp Abberant splicing confirmed in >50% of known case - limited by expression in blood Also new candidate variants identified #ESHG2026
Thank you @eshg.bsky.social #eshg2026 for another fabulous conference!! ๐Ÿ‡ธ๐Ÿ‡ช๐Ÿงฌ
Wendy Chung (Columbia) GUARDIAN Study approach to genomic newborn screening Focus on childhood-onset conditions - high penetrance - effective interventions - clear evidence base ๐Ÿ‘€ high uptake >92% of optional additional testing in conditions where above less clear #ESHG2026
2d
9h
3d
A Tucci: Prevalence of repeat expansion disorders. - Mutation freq โ‰  disease freq: disease prevalence model using carrier freq - Pathogenic repeat expansions more freq in genomic databases than expected from clinical prevalence - Two main factors: under ascertainment+incomplete penetrance #eshg2026
๐ŸšจSpecial Issue for #ESHG2026: โ€œDNA in public health screening programmesโ€ @eshg.bsky.social ๐Ÿ”นWhat should we screen for and report? ๐Ÿ”นWhat about uncertainty and harms? ๐Ÿ”นHow can we deliver equitably and at scale? #Genomics #Screening #NewbornScreening ๐Ÿ”— www.nature.com/collections/...
๐Ÿ‘‹๐Ÿงฌ Welcoming address #eshg2026 @ahoischen.bsky.social @eshg.bsky.social 3,171 abstracts from 95 countries: ๐Ÿ‡ฌ๐Ÿ‡ง๐Ÿ‡ฎ๐Ÿ‡น๐Ÿ‡น๐Ÿ‡ท๐Ÿ‡ฉ๐Ÿ‡ช๐Ÿ‡ช๐Ÿ‡ธ et al ๐Ÿ‘ฅ6,048 participants: ๐Ÿ™‹โ€โ™‚๏ธ๐Ÿ™‹โ€โ™€๏ธ4,812 in person ๐Ÿ’ป ๐Ÿ–ฅ๏ธ1,248 online โ›…๏ธ Fascinating word cloud from all presentation titles ๐Ÿ‡ธ๐Ÿ‡ช Itโ€™s good to be in Gothenburg! #RareDisease #Genomics
Brilliant ESHG Award Lecture by @tuuliel.bsky.social @eshg.bsky.social #eshg2026 highlighting the importance of building communal resources #genomics #openscience ๐Ÿ‘๐Ÿ‘๐Ÿ‘
Another great #genomic NBS workshop today at #eshg2026 @eshg.bsky.social Fantastic to see the focus shift towards HOW we do this! So much we need to scale up: public and professional engagement, infrastructure, workforce! While ensuring sustainability and equity ๐Ÿงฌ๐Ÿ‘ถ๐Ÿš€
2d
14h
3d
๐Ÿ‘๐Ÿ‘๐Ÿ‘ fantastic to see @nickywhiffin.bsky.social win the Leena Peltonen award at #eshg2026 @eshg.bsky.social ๐Ÿ‘๐Ÿ‘๐Ÿ‘
10h
Zornitza Stark
James Fasham
1d
James Fasham
Guillaume Canaud, Mendel Lecturer at #eshg2026! Professor Canaud is internationally recognised for his pioneering research into the molecular mechanisms of rare vascular disorders and for translating genetic discoveries into targeted therapies that are transforming patient care #Genetics #Genomics
3d
10h
European Journal of Human Genetics
Zornitza Stark
Zornitza Stark
Tom Wright
Zornitza Stark
Pilar Cacheiro
European Society of Human Genetics
The rapid technological progress makes it possible to use DNA testing in settings outside of clinical genetics services. This implies that public health ...
DNA in public health screening programmes
www.nature.com